These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25413926)

  • 1. Control of hospital endemicity of multiple-drug-resistant Acinetobacter baumannii ST457 with directly observed hand hygiene.
    Cheng VC; Chen JH; Poon RW; Lee WM; So SY; Wong SC; Chau PH; Yip CC; Wong SS; Chan JF; Hung IF; Ho PL; Yuen KY
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):713-8. PubMed ID: 25413926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.
    Anunnatsiri S; Tonsawan P
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):693-703. PubMed ID: 21706949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling endemic multidrug-resistant Acinetobacter baumannii in Intensive Care Units using antimicrobial stewardship and infection control.
    Cheon S; Kim MJ; Yun SJ; Moon JY; Kim YS
    Korean J Intern Med; 2016 Mar; 31(2):367-74. PubMed ID: 26874513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of multidrug-resistant Acinetobacter baumannii in Hong Kong: Role of environmental surveillance in communal areas after a hospital outbreak.
    Cheng VCC; Wong SC; Chen JHK; So SYC; Wong SCY; Ho PL; Yuen KY
    Am J Infect Control; 2018 Jan; 46(1):60-66. PubMed ID: 28893447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful control of carbapenem-resistant Acinetobacter baumannii in a Korean university hospital: a 6-year perspective.
    Cho OH; Bak MH; Baek EH; Park KH; Kim S; Bae IG
    Am J Infect Control; 2014 Sep; 42(9):976-9. PubMed ID: 25179329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach.
    Rodríguez-Baño J; García L; Ramírez E; Martínez-Martínez L; Muniain MA; Fernández-Cuenca F; Beltrán M; Gálvez J; Rodríguez JM; Velasco C; Morillo C; Perez F; Endimiani A; Bonomo RA; Pascual A
    Am J Infect Control; 2009 Nov; 37(9):715-22. PubMed ID: 19457584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation and management of an outbreak of multidrug-carbapenem-resistant Acinetobacter baumannii in Cambridge, UK.
    Enoch DA; Summers C; Brown NM; Moore L; Gillham MI; Burnstein RM; Thaxter R; Enoch LM; Matta B; Sule O
    J Hosp Infect; 2008 Oct; 70(2):109-18. PubMed ID: 18701189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation and control of an outbreak of imipenem-resistant Acinetobacter baumannii Infection in a Pediatric Intensive Care Unit.
    Hong KB; Oh HS; Song JS; Lim JH; Kang DK; Son IS; Park JD; Kim EC; Lee HJ; Choi EH
    Pediatr Infect Dis J; 2012 Jul; 31(7):685-90. PubMed ID: 22466324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors for carbapenem- and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipients.
    Kim SB; Min YH; Cheong JW; Kim JS; Kim SJ; Ku NS; Jeong SJ; Han SH; Choi JY; Song YG; Kim JM
    Scand J Infect Dis; 2014 Feb; 46(2):81-8. PubMed ID: 24325335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of fluoroquinolones is the single most important risk factor for the high bacterial load in patients with nasal and gastrointestinal colonization by multidrug-resistant Acinetobacter baumannii.
    Cheng VC; Chen JH; So SY; Wong SC; Yan MK; Chau PH; Lee WM; To KK; Chan JF; Hung IF; Ho PL; Yuen KY
    Eur J Clin Microbiol Infect Dis; 2015 Dec; 34(12):2359-66. PubMed ID: 26373714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West China.
    Liu Q; Li W; Du X; Li W; Zhong T; Tang Y; Feng Y; Tao C; Xie Y
    PLoS One; 2015; 10(6):e0130701. PubMed ID: 26083415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia.
    Nutman A; Glick R; Temkin E; Hoshen M; Edgar R; Braun T; Carmeli Y
    Clin Microbiol Infect; 2014 Dec; 20(12):O1028-34. PubMed ID: 24930471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of drug resistance of Acinetobacter baumannii and its related factors in ICU].
    Ma MY; Xu J; Yu N; Huang GM
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Nov; 25(11):686-9. PubMed ID: 24225215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multimodal intervention program to control a long-term
    Valencia-Martín R; Gonzalez-Galan V; Alvarez-Marín R; Cazalla-Foncueva AM; Aldabó T; Gil-Navarro MV; Alonso-Araujo I; Martin C; Gordon R; García-Nuñez EJ; Perez R; Peñalva G; Aznar J; Conde M; Cisneros JM;
    Antimicrob Resist Infect Control; 2019; 8():199. PubMed ID: 31827780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study.
    Jang TN; Lee SH; Huang CH; Lee CL; Chen WY
    J Hosp Infect; 2009 Oct; 73(2):143-50. PubMed ID: 19716203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of a hospital outbreak of extensively drug-resistant Acinetobacter baumannii using a multimodal intervention including daily chlorhexidine baths.
    Gray AP; Allard R; Paré R; Tannenbaum T; Lefebvre B; Lévesque S; Mulvey M; Maalouf L; Perna S; Longtin Y
    J Hosp Infect; 2016 May; 93(1):29-34. PubMed ID: 26876749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and molecular epidemiology of Acinetobacter baumannii bloodstream infections in an endemic setting.
    Marchaim D; Levit D; Zigron R; Gordon M; Lazarovitch T; Carrico JA; Chalifa-Caspi V; Moran-Gilad J
    Future Microbiol; 2017 Mar; 12():271-283. PubMed ID: 28287300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of endemic extensively drug-resistant Acinetobacter baumannii with a cohorting policy and cleaning procedures based on the 1 room, 1 wipe approach.
    Gavaldà L; Soriano AM; Cámara J; Gasull R; Arch O; Ferrer M; Shaw E; Granada RM; Dominguez MA; Pujol M
    Am J Infect Control; 2016 May; 44(5):520-4. PubMed ID: 26831279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of an outbreak of Acinetobacter baumannii infections using vaporized hydrogen peroxide.
    Chmielarczyk A; Higgins PG; Wojkowska-Mach J; Synowiec E; Zander E; Romaniszyn D; Gosiewski T; Seifert H; Heczko P; Bulanda M
    J Hosp Infect; 2012 Aug; 81(4):239-45. PubMed ID: 22727825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intervention to limit transmission of extremely drug-resistant Acinetobacter baumannii in patients who underwent surgery.
    Apisarnthanarak A; Warren DK
    Clin Infect Dis; 2013 Oct; 57(8):1215-6. PubMed ID: 23825356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.